Back to Journals » Drug Design, Development and Therapy » Volume 13
Caplacizumab as an emerging treatment option for acquired thrombotic thrombocytopenic purpura
Total article views | Abstract views | HTML views | PDF downloads | Totals | |
---|---|---|---|---|---|
9,078 | Dovepress* | 3,732 | 2,320+ | 1,254 | 6,052 |
PubMed Central* | 0 | 3,026 | 631 | 3,026 | |
Totals | 3,732 | 5,346 | 1,885 | 9,078 | |
*Since 17 April 2019 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar